Join the club for FREE to access the whole archive and other member benefits.

Ana Mulero

Multiplatform Journalist and Content Specialist

Ana Mulero has been reporting on pharma and biotech for nearly 10 years. Ana has held editorial and reporting positions at the Washington Business Journal, Industry Dive, FDA News, the Regulatory Affairs Professional Society and BioCentury. Previously, she worked at the Washington Business Journal, FierceHealthcare and The Hill Rag, among other publications. Her work has also appeared in Endpoints News, Xtelligent, BioWorld, HealthLeaders, among other publications.

Ana completed Bachelor’s of Arts in Communication with a Minor in Italian at Arizona State University. She earned her Master’s in Multiplatform Journalism from the University of Maryland, and is currently pursuing her second Master’s degree of MBA in Healthcare Management at the Florida Institute of Technology.

Visit website: https://www.biospace.com/staticpages/10284/contributors/#AnaMulero

 anitamulero

See also

Biospace

Digital hub for life science news and careers

Details last updated 03-Jul-2023

Articles written by Ana Mulero

UNITY Biotech's lead compound lags behind the Regeneron’s eye drug

UNITY Biotech's lead compound lags behind the Regeneron’s eye drug

Biospace - 27-May-2023

UBX1325 showed disappointing results in phase II macular degeneration trial - further analysis is required